Top life sciences and healthcare companies that are changing the world through innovation trust Caldwell for counsel on their legal and business objectives. We help clients become and remain market leaders and have developed lasting relationships with some of the most successful medical devices, biopharma, healthcare and diagnostic entities. Many of our esteemed practitioners hold higher degrees and prior careers in life sciences, including PharmD’s, bioengineering and chemical engineering. We have extensive experience in gene and cell therapies, small molecules and antibodies, global medical devices, pharmaceuticals, immunotherapies, DNA cloning and sequencing, and protein synthesis. Our lawyers possess deep industry and scientific knowledge, as well as an understanding of how life sciences companies are formed, financed, grown, and taken public or acquired based on decades of experience in scaling with companies from inception.
We represent numerous life sciences companies at all stages of growth, ranging from revolutionary startups to global entities looking into strategic acquisitions. Our service offerings include patent prosecution and litigation, entity formation, corporate venture, FDA clearance, technology transfer, mergers and acquisition, business litigation, and initial public offerings. We also have strong ties to venture capital and strategic investors focused on the life sciences industry. The deep industry knowledge our team possesses, paired with an understanding of how life science companies are formed, grown, and scaled, makes us a leading partner in the industry. Proudly, Caldwell boasts a USPTO allowance rate—the rate at which the USPTO issues patents—of over 99%.